Background: Recent analysis of Stenotrophomonas maltophilia has identified a novel family of resistance genes (Smqnr) encoding pentapeptide repeat proteins, which confer low-level resistance to quinolones. This study describes further novel variants present in clinical isolates of S. maltophilia and investigates their effect on resistance to a number of quinolones in an Escherichia coli host.
Introduction
Stenotrophomonas maltophilia is a non-fermentative Gramnegative bacillus responsible for a variety of opportunistic and nosocomial infections. 1 These can be difficult to treat, as the organism frequently exhibits multidrug resistance, 2 and the results of susceptibility testing vary according to the method used and may not correlate with in vivo efficacy. 3 As a result, co-trimoxazole, ticarcillin/clavulanate, minocycline and the newer fluoroquinolones (moxifloxacin and levofloxacin), either alone or in combination, are currently considered the most appropriate therapeutic agents. 4 Resistance is mediated by a relatively impermeable cell membrane, the production of b-lactamases (L1 and L2) 5 and an efficient resistance -nodulation-division (RND) efflux pump (SmeDEF) able to extrude fluoroquinolones, chloramphenicol and tetracycline. 6 Recent analysis of the whole genome sequence of S. maltophilia K279a revealed a number of other putative resistance genes thought to encode both further RND pumps and enzymes able to confer resistance to a number of antibiotics and heavy metals. 7 Examination of K279a and another S. maltophilia genome sequence (R551-3) also identified a novel family of genes (Smqnr) that encode proteins with homology to the Qnr quinolone protection proteins found in the Enterobacteriaceae. 8 These pentapeptide repeat proteins (QnrA, B and S) confer low-level quinolone resistance by protecting DNA gyrase and topoisomerases from inhibition and, in the Enterobacteriaceae, are usually located in association with other resistance determinants on large plasmids. 9 The origin of these plasmid-mediated qnr genes is thought to be the chromosome of aquatic or environmental bacteria (such as Shewanella algae and Vibrio splendidus), with horizontal transfer to other bacterial genera facilitated by the association of the genes with integrons and associated mobile genetic elements. The clinical importance of plasmid-mediated quinolone resistance is uncertain, although it is postulated that it may help to stabilize or select for mutations in the quinolone resistance-determining region (QRDR) of DNA gyrase and topoisomerase, which then confers high-level quinolone resistance. Aside from efflux, the mechanisms involved in quinolone resistance in S. maltophilia are unclear and mutations in the QRDR have not yet been found to be important. 11, 12 S. maltophilia isolates often display a phenotype of resistance to fluoroquinolones but susceptibility to nalidixic acid, 13 a phenomenon that is characteristic of Enterobacteriaceae isolates lacking both efflux-and QRDR-mediated resistance mechanisms and that is thought to be primarily mediated by Qnr.
14 As well as contributing to fluoroquinolone resistance in S. maltophilia, isolates carrying Smqnr genes may represent an important reservoir for the dissemination and spread of plasmid-mediated quinolone resistance amongst the Enterobacteriaceae. In this study, we report further variants of the Smqnr family present in clinical isolates of S. maltophilia and investigate their effect on resistance to a number of quinolone antibiotics when expressed in an Escherichia coli host.
Materials and methods

Characterization of bacterial isolates
S. maltophilia isolates were collected from clinical samples (sputum and blood) over a 2 year period, and were identified by oxidase tests and biochemical profiling with API 20NE (bioMérieux, Basingstoke, UK). Susceptibility to co-trimoxazole was determined by the BSAC disc diffusion method. 15 Susceptibility testing to other antimicrobials, including levofloxacin, ciprofloxacin, gentamicin, amikacin and ceftazidime, was performed using the MicroScan WalkAway System and the Negative Combo 42 panel (Siemens Healthcare Diagnostics, Deerfield, IL, USA), interpreted using CLSI breakpoints. 16 
Molecular typing
Random amplified polymorphic DNA (RAPD)-PCR typing of S. maltophilia isolates was carried out using Ready-To-Go RAPD Analysis Beads (Amersham Biosciences UK Ltd, Buckinghamshire, UK), 50 ng of S. maltophilia DNA and 25 pmol of the oligonucleotide primer 5 0 -GGTGCGGGAA-3 0 . Thermocycling conditions were 1 cycle of 958C for 5 min, followed by 45 cycles of 958C for 1 min, 368C for 1 min and 728C for 2 min. Banding profiles were visualized after electrophoresis in 2% agarose gels.
PCR detection of Smqnr alleles
PCR for the Smqnr gene was carried out using the SmqnrX set of primers (5 0 -ACACAGAACGGCTGGACTGC-3 0 and 5 0 -TTCAACGACGTGGAGCTGT-3 0 ), which amplify an 811 bp fragment containing the entire Smqnr coding sequence. 8 All PCRs were performed using Thermoprime Plus Mastermix (ABgene, Epsom, UK) and 2 mL of DNA template, prepared by boiling a single bacterial colony in 100 mL of nuclease-free water. Products were separated on 1.5% agarose gels and purified using Qiaquick PCR purification kits (Qiagen Inc., Crawley, UK).
Cloning and sequence analysis of Smqnr alleles
Purified Smqnr amplicons were ligated to the pCR-Blunt II -TOPO vector (Invitrogen Inc., Paisley, UK) and transformed in chemically competent E. coli TOP10 cells (Invitrogen). Transformants were selected after growth on Luria-Bertani (LB) agar supplemented with kanamycin (25 mg/L). Colonies carrying inserts were identified by PCR using SmqnrX primers and plasmids were extracted using a QIAprep Spin Miniprep Kit (Qiagen) after overnight incubation in 3 mL of LB broth. The full sequence and orientation of Smqnr inserts was determined using BigDye v2 fluorescent end terminator technology, a 96 capillary Prism 3700 sequencer (Applied Biosystems, Warrington, UK) and M13 forward and reverse vector-specific primers. Chromatograms were analysed and consensus sequences assembled using GeneTool Lite v1.0. Only constructs containing the Smqnr allele cloned in the sense orientation under control of the Sp6 P lac promoter were selected for further analysis.
Expression of Smqnr alleles in E. coli TOP10
To confirm that Smqnr genes were expressed in E. coli TOP10, the production of Smqnr transcripts was confirmed by RT-PCR and SmQnr proteins were confirmed by SDS-PAGE. Cells were grown in LB broth supplemented with kanamycin, harvested at mid-log phase and adjusted to an OD 600 of 0.4-0.6. RNA was extracted using RNeasy Mini Kits (Qiagen) and treated with DNase I (DNA-free kit, Ambion, Huntingdon, UK) to remove DNA contamination. Qualitative RT-PCR was performed using Reverse-iT TM One-Step reagents (ABgene), 200 ng of RNA template and SmqnrX primers. Thermocycling conditions were 478C for 30 min and 948C for 2 min, followed by 35 cycles of 948C (20 s), 588C (30 s) and 728C (3 min), and a final extension at 728C for 5 min. DNA contamination was excluded by the inability to amplify Smqnr in standard PCRs performed on the RNA preparations. For SDS-PAGE, cells were resuspended in 500 mL of lithium dodecyl sulphate ('LDS') sample buffer and heated at 968C for 5 min. Proteins were separated by SDS-PAGE using NuPAGE w Novex 4%-12% Bis-Tris Gels (Invitrogen) and visualized following Coomassie w staining with SimplyBlue TM SafeStain (Invitrogen).
Susceptibility testing of transformants
The MICs of levofloxacin, ciprofloxacin, ofloxacin, gatifloxacin, nalidixic acid, norfloxacin, moxifloxacin, gemifloxacin and enrofloxacin for all E. coli transformants carrying novel Smqnr alleles were determined by Etest after incubation for 18 h on Iso-Sensitest agar (Oxoid, Basingstoke, UK).
Multiple alignments
Peptide sequences were determined using the Expasy translate tool and compared with known Smqnr allele sequences using Blastx and Blastp. Alleles were considered to be novel if they resulted in one or more amino acid changes compared with those already in GenBank and were named numerically in accordance with accepted qnr nomenclature. 17 Multiple alignments of all Smqnr sequences were performed by ClustalW2 analysis (www.ebi.ac.uk/Tools/clustalw2/index.html). 18 
Nucleotide accession numbers
The sequences of the following isolates have been submitted to GenBank and assigned the indicated accession numbers: isolate smC1, FJ596752 (Smqnr12); CR37, FJ596753 (Smqnr13); CR78, FJ596754 (Smqnr14); smC5, FJ596755 (Smqnr15); smC2, FJ596756 (Smqnr16); smC9, FJ596757 (Smqnr17); and smC11, FJ596758 (Smqnr18).
Results
Antimicrobial susceptibility of S. maltophilia isolates
Smqnr alleles were amplified from 13 S. maltophilia isolates obtained from clinical specimens. Characteristics and antimicrobial susceptibility as determined by MicroScan are shown in Table 1 . Five isolates were resistant to ciprofloxacin and five others exhibited reduced susceptibility (MIC 2 mg/L). The MIC of nalidixic acid was .4 mg/L for all isolates, while levofloxacin (12/13 isolates susceptible) and gemifloxacin (6/9 susceptible) were the most active quinolones. All isolates exhibited resistance Gordon and Wareham to aminoglycosides, cephalosporins, b-lactam/inhibitor combinations and carbapenems; two were resistant to trimethoprim/ sulfamethoxazole.
Epidemiological typing
RAPD typing was used to investigate the relatedness of the 13 isolates studied. Twelve unique RAPD profiles were obtained (Figure 1 ). Isolates smC10 and smC13 had indistinguishable profiles and were also found to contain the same Smqnr gene.
Analysis of Smqnr genes
Smqnr was successfully cloned in the correct orientation in the pCR-Blunt II -TOPO vector. Analysis of the nucleotide sequences revealed that six corresponded to the previously identified Smqnr8 (n ¼ 3), Smqnr10 (n¼ 1) and Smqnr11 (n ¼ 2) alleles, whilst seven sequences were new. Examination of the peptide sequences of the novel sequences confirmed that they encoded new SmQnr proteins, designated SmQnr12 -18 ( Figure 2) .
Expression of Smqnr genes in E. coli TOP10
Expression of Smqnr genes in E. coli TOP10 transformants was confirmed by RT-PCR and SDS-PAGE. RNA transcripts were successfully amplified from all RNA preparations, except for the E. coli TOP10 control strain. Likewise, a protein band of 24 kDa (predicted molecular mass of SmQnr ¼24.17 kDa) was present in protein preparations made from the Smqnr transformants, but was absent in the control strain ( Figure 3 ).
Effect of SmQnr on quinolone susceptibility
To determine the effect of SmQnr12 -18 on susceptibility to quinolones, MICs were determined for E. coli TOP10 cells transformed with the plasmid constructs. The results are shown in Table 2 . An increase in the MIC compared with the E. coli wild-type for at least two quinolones was seen for all strains carrying Smqnr alleles. There were minimal effects on gemifloxacin and norfloxacin, whilst a reduction in the susceptibility of all isolates was seen with ciprofloxacin. Although marked increases in the MIC were observed for some strains, none was large enough to constitute frank resistance according to available E. coli breakpoints.
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Phylogenetic comparison of SmQnr proteins
The novel SmQnr peptide sequences identified were compared with those deposited in GenBank previously as SmQnr1 -11 (accession numbers AB430839 -AB430843 and AB430845 - S. maltophilia quinolone resistance 485 JAC AB430850) and a further 16 SmQnr sequences (GenBank accession numbers EU681371 -EU681385 and NC_010943.1) recently identified in other S. maltophilia isolates. In total, 27 of all the peptide sequences compared were unique, as 7 of the sequences found in GenBank corresponded to SmQnr1 (strain G51), SmQnr8 (strains E847 and K279a), SmQnr9 (strain D388), SmQnr12 (strains F375 and D457) and SmQnr17 (CO48). The alignment of all 27 SmQnr proteins is shown in Figure 2 and their phylogenetic relationships in Figure 4 .
Discussion
The plasmid-borne quinolone resistance gene qnr was first identified in a Klebsiella pneumoniae isolate in 1998. In recent years, FNGATLKEASFRSCDISMCHFSFIKALGLEISECRAQGADFSNASFMNQITTRSWFCSAF 120 *********.**.********.*::****** ******** *.********.** ***** Figure 2 . Amino acid sequence alignments of 27 SmQnr proteins. Asterisks, identical amino acids; colons, strongly similar amino acids (conserved substitutions); full stops, weakly similar amino acids (semi-conserved substitutions); spaces, variable amino acids. Amino acid differences are shown in grey boxes.
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In our study, we identified a further seven variants of Smqnr, bringing the total number of variants present in S. maltophilia to at least 27. 26 The ability of these variants to confer quinolone resistance when expressed in an E. coli host was further investigated. In accordance with other studies, nearly all of the genes affected susceptibility to quinolones to some extent 8, 26 and marked effects were seen on susceptibility to ciprofloxacin. It is possible that mobilization of qnr-like Gordon and Wareham genes from S. maltophilia to Enterobacteriaceae may have played a role in driving resistance to fluoroquinolones in clinical practice.
There was little correlation between the Smqnr allele carried and resistance to quinolones in the S. maltophilia clinical isolates. The importance of Smqnr to high-level quinolone resistance in S. maltophilia is therefore likely to be minimal, although it is possible that it may provide protection to low concentrations of quinolones, which may be present in the environment. The chromosomal location and apparent presence of Smqnr in all strains of S. maltophilia suggests that they may be important in protecting DNA gyrases from other substances or conditions found in their environmental niche.
In summary, this study provides further information on the diversity of qnr-like genes and their ability to reduce susceptibility to quinolone antibiotics in an unrelated bacterial host.
